OCEANSIDE, California — International Stem Cell Corporation (OTCBB:ISCO), www.intlstemcell.com, announced today that it had entered into a Memorandum of Understanding with ARG Vermogensverwaltung AG (“ARG”), a German Investment Fund, to create a new European subsidiary (“ISCO Europe”) to be funded with up to $10 million of capital derived from ARG and other independent sources in […]
BioTime, Inc. (AMEX:BTIM) announced today that on August 1, 2010 the Company will be offering for sale 21 new stem cell products for research use only. These products will include the novel stem cell lines: E120 expressing the gene LGR5 useful in colon cancer drug discovery, EN16, T43, RAD20.5, RA-SKEL8, SM22, and Z1, full properties […]
International Stem Cell Corporation (OTCBB: ISCO), www.internationalstemcell.com, and Insight Bioventures India Private Limited (IBVI), (www.insightbioventures.in) announced today that they have signed a letter of intent concerning funding and establishment of an Indian affiliate of ISCO (ISCO India). The goal is to establish world-class development and manufacturing operations for ISCO’s research and pharmaceutical products in India, […]
CHO-K1 kit to be highly efficient for drug discovery. Original Study published online by Journal of Biomolecular Screening Paris – Cellectis bioresearch, the specialist in genome customizationand a subsidiary of Cellectis (Alternext: ALCLS), today announced the publication of a scientific study describing a novel method, based on meganuclease-driventargeted integration, for the generation of stable cell […]
Rostock, Germany – Bionas GmbH announces the launch of its new Bionas® adcon reader for impedance-based, cellular analysis. The Bionas adcon reader technology is based on real-time monitoring of cellular impedance, thus giving real-time data about cell adhesion, membrane integrity, cellular morphology and cell proliferation for applications in toxicology, oncology, receptor signaling as well as […]
BioTime, Inc. Provides Financial Information about Its Acquisition of ES Cell International Pte Ltd.
BioTime, Inc. (NYSE Amex: BTIM) filed an amendment to its Current Report on Form 8-K with the Securities and Exchange Commission reporting BioTime’s acquisition of ES Cell International Pte Ltd, a Singapore private limited company (‘ESI’). BioTime filed the amendment in the time frame provided in the SEC’s rules to include audited financial statements of […]
Transaction creates EUR 2.1 billion (US$2.9 billion) world-class partner for the Life Science sector High-level organizational structure in place and senior management team appointed: Merck Chemicals Head Bernd Reckmann to lead Merck Millipore Merck Chemicals now comprises two new divisions: Merck Millipore and Performance Materials Darmstadt, Germany – Merck KGaA, a global pharmaceutical and chemical […]
Enables Reliable Production of Consistent, High Quality Cell Plates for Transport Assays. The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications is pleased to announce it has begun installations of its new CompacT SelecT Advanced Plating Module (APM), an innovative alternative to the established CompacT […]
Utilizing Fluidigm Corporation’s Dynamic Array™ and Digital Array™ integrated fluidic circuits (IFCs), Stanford University researchers to have discovered a much larger spectrum of differences between individual cells than has previously been demonstrated. Among these differences are the communication capabilities that emerge from the interactions of genetic circuitry that mediates cell-to-cell communication. The university also used […]
Furukawa Electric (TOKYO:5801)(ISIN:JP3827200001) have commercialized the world’s first damage-less cell sorter (PERFLOW Sort), an instrument for analyzing and sorting living cells, especially human induced pluripotential stem (iPS) cells and human embryonic stem (ES) cells with inducible pluripotency to differentiate into various cell types. Different from the conventional sorting methods including ultrasonic wave, charge and high […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
